Publication Details IDRI’s Promising Leprosy Vaccine Candidate

April 26th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | April 26, 2018: A publication in Nature Partner Journals (npj) Vaccines indicates that post-exposure prophylaxis with LepVax, IDRI’s leprosy vaccine candidate, not only appears safe but, unlike BCG (a tuberculosis vaccine that provides some protection [...]

IDRI Names New Chief Operating Officer and Chief Scientific Officer

April 6th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | April 6, 2018: As IDRI (Infectious Disease Research Institute) celebrates its 25th anniversary in 2018, the organization is developing a strategic plan to hone current strengths while embarking upon bold new initiatives including next generation [...]

IDRI Partners to Develop a New Vaccine to Prevent Transmission of Malaria

March 29th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | March 29, 2018: The Global Health Innovative Technology Fund (GHIT) has awarded the University of Florida (UF) and partners, including IDRI (Infectious Disease Research Institute), $3.2 million to advance a promising vaccine to prevent transmission [...]

IDRI TB Vaccine Candidate Shows Success in Initial Trial

March 24th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | March 24, 2018 : Researchers at IDRI (Infectious Disease Research Institute), the South African Tuberculosis Vaccine Initiative (SATVI) at the University of Cape Town (UCT) and Aeras have released the first results from a clinical trial [...]

IDRI Receives $3.8 Million for TB Drug Discovery

March 23rd, 2018|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | March 23, 2018: IDRI’s tuberculosis drug discovery efforts continue to expand with a recently awarded grant extension of $3.8 million from the Bill & Melinda Gates Foundation. The additional funding was awarded to Tanya [...]

Seattle Lawyer Cindy Runger Joins IDRI Board of Directors

October 19th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: Seattle, WA | Oct. 19, 2017: Cindy Runger, a senior finance and legal executive who most recently served in a leadership role with U.S. Trust, has joined the Board of Directors of IDRI (Infectious Disease Research [...]

Promising New Leprosy Vaccine Moves into Human Trials

October 12th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE, WA, & GREENVILLE, SC | Oct. 12, 2017: Today marks a significant step forward in the prevention and treatment of leprosy as the Infectious Disease Research Institute (IDRI) and American Leprosy Missions announce the start of a [...]

IDRI Collaborates on Novel Vaccine for Ebola & Other Hemorrhagic Fever Viruses

October 5th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | Oct. 5, 2017: IDRI (Infectious Disease Research Institute) is part of a new consortium formed to prepare and test a vaccine formulation designed to protect against the Ebola, Sudan, Marburg, and Lassa fever viruses. If successful, [...]

Quratis Teams with IDRI on TB Vaccine

August 30th, 2017|Press Releases|

SEATTLE & SEOUL | Aug. 30, 2017 FOR IMMEDIATE RELEASE: Quratis Inc. announced Wednesday that the company had applied for the phase 2 of clinical trials in Korea for an adult tuberculosis vaccine developed by scientists at the Infectious Disease Research Institute [...]

IDRI to Continue Development of Inhalable TB Drug Candidate

August 24th, 2017|Press Releases|

  IDRI's Steve Reed, left, signs TB agreement with Hisun officials as part of a ceremony to commemorate the 30th anniversary of the friendship relationship between the state of Indiana and Zheijiang Province. SEATTLE | Aug. 24, 2017 FOR [...]

Load More